Abstract: A device may receive client equipment information for a set of client equipment associated with an organization. The device may receive information describing a set of equipment management services being offered by one or more vendor organizations. The device may identify a subset of the set of equipment management services to offer an individual associated with the organization. The device may provide, for display via an interface of a program, information describing the subset of the set of equipment management services. The device may receive, from a client device that is accessing the interface, information identifying a selection of a particular equipment management service, of the subset of the set of equipment management services, for particular client equipment of the set of client equipment. The device may perform one or more actions associated with assisting in performance or delivery of the particular equipment management service that has been selected.

Abstract: A device may receive client equipment information for a set of client equipment associated with an organization. The device may receive information describing a set of equipment management services being offered by one or more vendor organizations. The device may identify a subset of the set of equipment management services to offer an individual associated with the organization. The device may provide, for display via an interface of a program, information describing the subset of the set of equipment management services. The device may receive, from a client device that is accessing the interface, information identifying a selection of a particular equipment management service, of the subset of the set of equipment management services, for particular client equipment of the set of client equipment. The device may perform one or more actions associated with assisting in performance or delivery of the particular equipment management service that has been selected.

Abstract: A device and method for reducing swirl in a gas compressor is provided. The device can include a tubular or annular seal body having an abradable interior surface for use in forming a seal. The tubular body can further have a plurality of swirl teeth arranged on a high pressure side of the seal body. The swirl teeth are disposed so as to form swirl slots between the adjacent swirl teeth. The swirl teeth can have a brake chord and a brake pitch describing the length and separation of each adjacent swirl tooth. The ratio of the brake pitch to the brake chord can be optimized in order to maximize creation of free vortices between the swirl teeth as the compressor rotates for swirl reduction.

Abstract: A device and method for reducing swirl in a gas compressors is provided. The device can include a tubular or annular seal body having an abradable interior surface for use in forming a seal. The tubular body can further have a plurality of swirl teeth arranged on a high pressure side of the seal body. The swirl teeth are disposed so as to form swirl slots between the adjacent swirl teeth. The swirl teeth can have a brake chord and a brake pitch describing the length and separation of each adjacent swirl tooth. The ratio of the brake pitch to the brake chord can be optimized in order to maximize creation of free vortices between the swirl teeth as the compressor rotates to for swirl reduction.

Abstract: The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions.

Abstract: The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food. The invention also provides a kit comprising a pharmaceutical composition comprising a therapeutically effective amount of glycopyrrolate and a pharmaceutically acceptable carrier, prescribing information including advice regarding the administration of glycopyrrolate without food to improve bioavailability, and a container.

Abstract: Provided are vitamin compositions and methods for the treatment or prevention of conditions associated with hormonal changes in an individual. The vitamin compositions contain calcium, vitamin D, folic acid, vitamin B12 and vitamin B6. In a preferred embodiment, the vitamin B12 is a hydroxocobalamin.

Abstract: Provided are vitamin compositions and methods for the treatment of dementia and vascular diseases, including cardiovascular diseases. The vitamin compositions comprise vitamin B12, vitamin B6, folic acid, magnesium and vitamin E.

Abstract: The present invention is directed to methods and compositions for treating upper respiratory indications, such as the treatment, management or mitigation of cough, cold, cold-like symtoms, symtoms related to upper respiratory infections, influenza symptoms and allergic rhinitis, perennial rhinitis, nasal and Eustachian tube congestion in an animal by administration of tannate compositions comprising single agent formulations or combinations of at least one or more agents into a single administrative dose.

Abstract: The present invention is directed to methods and compositions for treating upper respiratory indications, such as the treatment, management or mitigation of cough, cold, cold-like symptoms, symptoms related to upper respiratory infections, influenza symptoms and allergic rhinitis, perennial rhinnitis, nasal and Eustachian tube congestion in an animal by administration of tannate compositions comprising single agent formulations or combinations of at least one or more agents into a single administrative dose.

Abstract: The present invention is directed to methods and compositions for treating upper respiratory indications, such as the treatment, management or mitigation of cough, cold, cold-like symptoms, symptoms related to upper respiratory infections, influenza symptoms and allergic rhinitis, perennial rhinnitis, nasal and Eustachian tube congestion in an animal by administration of tannate compositions comprising combinations of at least one or more agents into a single administrative dose.

Abstract: The present invention is directed to methods and compositions for treating cardiac indications, such as heart failure, hypertension and congestive heart failure, in an animal by administration of compositions comprising combinations of at least two or more agents into a single administrative dose. Such compositions and methods provide a means to treat cardiac indications with several agents with out administering multiple individual agents either concurrently or separately. Methods and compositions comprising combinations of at least two or more agents provide a way to administer multiple agents that is easier for patients to use, is more easily administered by caregivers, and that facilitates the physicians determination of drug interactions, patient side effects and dosages.